Mental health studies with practical context.

A Phase Ib, Multicentre, Randomised, Double Blind, Placebo Controlled, 2 Sequence Crossover Trial to Evaluate the Effects of BI 3031185 on Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

This study evaluated the safety of TV-46000 for people with schizophrenia.

Researchers are studying Iclepertin, tracking side effects to assess long-term safety in people with schizophrenia.

Researchers compared BI 1358894, placebo and Quetiapine to find out how the approaches affected depression symptoms in people with depression.

A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia

Researchers compared MK-8998, Comparator: Olanzapine and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

Researchers compared MK0249, Concerta (methylphenidate) and placebo, tracking side effects to assess safety in adults with ADHD.

An Open-Label, Multicenter, Twelve-Month Study of Safety and Tolerability in the Treatment of Schizophrenia

A Phase Ib, Multi-center, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial to Evaluate the Effects on Impulsivity, Pharmacokinetics, Safety, and Tolerability of Oral BI 1356225 in Patients With Opioid Use Disorder Taking Background Buprenorphine Treatment

Researchers compared BI 1358894 and placebo to find out how the approaches affected post-traumatic stress symptoms in people with PTSD.

A Pilot Study of the Fathering Through Change Intervention for Fathers With Substance Use Disorders

Usage Patterns of OTC Nicotine Patches: Consumer Survey